Drug intelligence / Profile preview

heat shock protein 70

Development stage
Unknown
Lead developer
UConn Health
Modality
Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intranasal, Subcutaneous/intradermal/intravenous Injection
01

Overview

Heat shock protein 70 (Hsp70) is a highly conserved family of molecular chaperone proteins found in virtually all living organisms. It plays a crucial role in cellular protection against various forms of physiological stress by assisting in the proper folding of nascent and stress-accumulated misfolded proteins, preventing aggregation, and facilitating the refolding or degradation of damaged proteins. Hsp70 also inhibits both caspase-dependent and caspase-independent apoptosis, thereby promoting cell survival under adverse conditions[1][2][3]. In addition to its intracellular functions, membrane-bound and extracellular forms have been identified with potential roles as therapeutic targets in cancer and neurodegenerative diseases[2]. Recombinant or exogenous Hsp70 has demonstrated tissue-protective effects in models of ischemic injury, neurodegeneration, inflammation, and cardiovascular disease[6]. Pharmacological induction or administration of recombinant Hsp70 is being explored for its neuroprotective properties as well as immunomodulatory effects relevant to oncology (e.g., cancer vaccines)[3][5][7].

Other names
70 kilodalton heat shock proteinHSP70HSP-70HSP 70recombinant 70-kD heat-shock proteinrecombinant70-kD heat-shock proteinrecombinant-70-kD heat-shock protein
02

Targets

LRP1 (Prolow-density lipoprotein receptor-related protein 1)PS (Phosphatidylserine)Tumor-derived or pathogen-derived antigenic peptide

Beyond the preview

Go deeper on heat shock protein 70.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heat shock protein 70.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call